KYOTO FINL GROUP INC by Kyoto Financial Group Inc. 株価情報 (OTC: KYFGF)

最新ニュース KYOTO FINL GROUP INC by Kyoto Financial Group Inc. (OTC:KYFGF) 株価情報

KYOTO FINL GROUP INC by Kyoto Financial Group Inc.

Piper Sandler analyst Stephanie Wissink maintains Build-A-Bear Workshop (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBW#NYSE">BBW</a>) with a Overweight and raises the price target from $35 to $39.

News

Price Target

Analyst Ratings

Piper Sandler Maintains Overweight on Build-A-Bear Workshop, Raises Price Target to $39

Truist Securities analyst David Smith maintains Charles Schwab (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCHW#NYSE">SCHW</a>) with a Buy and raises the price target from $84 to $97.

SCHW

Truist Securities Maintains Buy on Charles Schwab, Raises Price Target to $97

Truist Securities analyst Jake Bartlett maintains Shake Shack (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHAK#NYSE">SHAK</a>) with a Buy and raises the price target from $134 to $140.

SHAK

Truist Securities Maintains Buy on Shake Shack, Raises Price Target to $140

Rumors

Trading Ideas

PLTR

Watching Palantir Technologies; Hearing Investor Business Daily SwingTrader Bought The Stock

RBC Capital analyst Luca Issi maintains Adverum Biotechnologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADVM#NASDAQ">ADVM</a>) with a Sector Perform and lowers the price target from $5 to $4.

ADVM

RBC Capital Maintains Sector Perform on Adverum Biotechnologies, Lowers Price Target to $4

Truist Securities analyst Terry Tillman maintains Riskified (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RSKD#NYSE">RSKD</a>) with a Buy and raises the price target from $7 to $8.

RSKD

Truist Securities Maintains Buy on Riskified, Raises Price Target to $8

https://about.fb.com/news/2025/05/advancing-accessibility-meta/#:~:text=Starting%20today%2C%20we're%20introducing,people%20ask%20about%20their%20environment.

Reported Earlier: Meta Platforms Says "You Can Now Customize Meta AI To Provide Detailed Responses On Ray-Ban Meta Glasses, A Feature That's Built To Assist Everyone, But Can Have Particular Value To People With Disabilities"

DA Davidson analyst Gil Luria maintains Dynatrace (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DT#NYSE">DT</a>) with a Buy and raises the price target from $60 to $65.

DA Davidson Maintains Buy on Dynatrace, Raises Price Target to $65

Truist Securities analyst Scot Ciccarelli maintains European Wax Center (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EWCZ#NASDAQ">EWCZ</a>) with a Buy and raises the price target from $5 to $6.

EWCZ

Truist Securities Maintains Buy on European Wax Center, Raises Price Target to $6

WIIM

PNBK

Patriot National Bancorp shares are trading lower after the company announced a $250 million mixed shelf offering.

DA Davidson analyst Rudy Kessinger maintains Okta (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OKTA#NASDAQ">OKTA</a>) with a Buy and raises the price target from $125 to $145.

OKTA

DA Davidson Maintains Buy on Okta, Raises Price Target to $145

CTXR

Citius Pharmaceuticals shares are trading lower after the company reported worse-than-expected Q2 EPS results.

EDBL

Edible Garden shares are trading lower after the company reported mixed Q1 financial results.

Exclusives

EXCLUSIVE: Hightower Advisors' Stephanie Link Says 'Added KKR this past week w the stock down 15% ytd and a play on growth, real assets, infrastructure and fee growth.'; Says 'BA has been my favorite stock for 2025'

PAVM

PAVmed shares are trading lower after the company reported a year-over-year decrease in Q1 sales results.

<a href="https://www.bloomberg.com/news/articles/2025-05-15/thoma-bravo-is-said-to-sell-remaining-3-4-billion-nasdaq-stake" title="https://www.bloomberg.com/news/articles/2025-05-15/thoma-bravo-is-said-to-sell-remaining-3-4-billion-nasdaq-stake">https://www.bloomberg.com/news/articles/2025-05-15/thoma-bravo-is-said-to-sell-remaining-3-4-billion-nasdaq-stake</a>

NDAQ

'Thoma Bravo Sells Remaining $3.4 Billion Nasdaq Stake' - Bloomberg News

DA Davidson analyst Gil Luria maintains Riskified (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RSKD#NYSE">RSKD</a>) with a Buy and raises the price target from $6 to $6.5.

DA Davidson Maintains Buy on Riskified, Raises Price Target to $6.5

FONR

Fonar shares are trading higher after the company reported a year-over-year increase in Q3 financial results.

RBC Capital analyst Brian Abrahams maintains Aardvark Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AARD#NASDAQ">AARD</a>) with a Outperform and lowers the price target from $21 to $20.

Comments

KYOTO FINL GROUP INC by Kyoto Financial Group Inc.

ニュース

最新ニュース KYOTO FINL GROUP INC by Kyoto Financial Group Inc. (OTC:KYFGF) 株価情報

ニュース

パートナーシップ

ベンジンガ・グローバル